Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Noriko Togashi
The New-Generation Selective ROS1/NTRK Inhibitor DS-6051b Overcomes Crizotinib Resistant ROS1-G2032R Mutation in Preclinical Models
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Related publications
P-Loop Conformation Governed Crizotinib Resistance in G2032r-Mutated ROS1 Tyrosine Kinase: Clues From Free Energy Landscape
PLoS Computational Biology
Molecular Neuroscience
Evolution
Ecology
Genetics
Behavior
Molecular Biology
Systematics
Simulation
Cellular
Computational Theory
Mathematics
Modeling
ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib
BMC Cancer
Cancer Research
Oncology
Genetics
P075 Hippo-Yap Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer
Cancer Discovery
Oncology
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The HSP90 Inhibitor Ganetespib Synergizes With the MET Kinase Inhibitor Crizotinib in Both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
Cancer Research
Cancer Research
Oncology
ROS1 Rearrangements Are Only Found in Lung Adenocarcinomas With Diffuse Strong IHC Expression of ROS1
Pathology
Forensic Medicine
Pathology
